MDxHealth Historical Income Statement
| MDXH Stock | USD 1.88 0.17 9.94% |
Historical analysis of MDxHealth income statement accounts such as Total Revenue of 73.7 M can show how well MDxHealth SA ADR performed in making a profits. Evaluating MDxHealth income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of MDxHealth's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining MDxHealth SA ADR latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether MDxHealth SA ADR is a good buy for the upcoming year.
MDxHealth |
About MDxHealth Income Statement Analysis
MDxHealth SA ADR Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to MDxHealth shareholders. The income statement also shows MDxHealth investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
MDxHealth Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts MDxHealth SA ADR generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of MDxHealth SA ADR. It is also known as MDxHealth overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from MDxHealth's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into MDxHealth SA ADR current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MDxHealth SA ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. As of now, MDxHealth's Total Revenue is increasing as compared to previous years. The MDxHealth's current Gross Profit is estimated to increase to about 46.1 M, while Operating Income is projected to decrease to (28.7 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1.9M | 6.1M | 5.6M | 5.9M | Depreciation And Amortization | 3.0M | 4.9M | 6.9M | 7.2M |
MDxHealth income statement Correlations
Click cells to compare fundamentals
MDxHealth Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MDxHealth income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 3.2M | 3.3M | 3.0M | 4.9M | 6.9M | 7.2M | |
| Interest Expense | 318K | 1.3M | 1.9M | 6.1M | 5.6M | 5.9M | |
| Selling General Administrative | 5.7M | 4.1M | 5.1M | 23.5M | 23.0M | 24.2M | |
| Total Revenue | 11.8M | 18.4M | 22.2M | 37.1M | 70.2M | 73.7M | |
| Gross Profit | (144K) | 7.8M | 10.4M | 19.2M | 43.9M | 46.1M | |
| Other Operating Expenses | 55.0M | 45.5M | 49.1M | 75.0M | 97.5M | 102.4M | |
| Operating Income | (43.2M) | (27.1M) | (26.8M) | (37.9M) | (27.3M) | (28.7M) | |
| Ebit | (43.2M) | (27.1M) | (27.0M) | (41.3M) | (37.3M) | (35.5M) | |
| Research Development | 9.0M | 4.5M | 6.7M | 7.6M | 6.4M | 5.4M | |
| Ebitda | (39.9M) | (23.8M) | (24.0M) | (36.4M) | (30.5M) | (28.9M) | |
| Cost Of Revenue | 11.9M | 10.5M | 11.8M | 17.8M | 26.3M | 27.6M | |
| Total Operating Expenses | 43.0M | 35.0M | 37.3M | 57.1M | 71.3M | 74.8M | |
| Income Before Tax | (43.7M) | (28.7M) | (29.0M) | (44.0M) | (43.1M) | (40.9M) | |
| Total Other Income Expense Net | (506K) | (1.5M) | (2.2M) | (6.1M) | (15.8M) | (15.0M) | |
| Net Income | (32.5M) | (43.1M) | (30.0M) | (30.9M) | (50.2M) | (40.9M) | |
| Income Tax Expense | (575K) | 1.3M | 1.9M | 6.1M | 1K | 950.0 | |
| Selling And Marketing Expenses | 4.4M | 2.3M | 2.6M | 26.6M | 36.9M | 38.8M | |
| Tax Provision | (575K) | 0.0 | 1K | (128K) | 128K | 134.4K | |
| Net Interest Income | (502K) | (1.5M) | (2.0M) | (6.1M) | (11.2M) | (10.6M) | |
| Interest Income | 10K | 4K | 11K | 125K | 1.1M | 1.1M | |
| Net Income From Continuing Ops | (43.1M) | (28.7M) | (29.0M) | (44.0M) | (44.8M) | (47.1M) | |
| Reconciled Depreciation | 3.4M | 3.3M | 3.0M | 4.9M | 7.3M | 4.2M | |
| Net Income Applicable To Common Shares | (43.1M) | (28.7M) | (29.0M) | (44.0M) | (39.6M) | (41.6M) |
Currently Active Assets on Macroaxis
When determining whether MDxHealth SA ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MDxHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mdxhealth Sa Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mdxhealth Sa Adr Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MDxHealth SA ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MDxHealth. If investors know MDxHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MDxHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Revenue Per Share 3.099 | Quarterly Revenue Growth 0.205 | Return On Assets (0.11) | Return On Equity (2.41) |
The market value of MDxHealth SA ADR is measured differently than its book value, which is the value of MDxHealth that is recorded on the company's balance sheet. Investors also form their own opinion of MDxHealth's value that differs from its market value or its book value, called intrinsic value, which is MDxHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MDxHealth's market value can be influenced by many factors that don't directly affect MDxHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MDxHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if MDxHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MDxHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.